A phase II trial of epirubicin, oxaliplatin, and capecitabine (EOX) as first-line chemotherapy in advanced gastric cancer: a Chinese single-center experience.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples